| Institution: | 1. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ONT, Canada;2. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ONT, Canada;3. Department of Psychiatry, University of Toronto, Toronto, ONT, Canada;1. Service de Biochimie, Centre de Biologie Humaine (CBH), CHU Amiens Sud, France;2. EA4666, Université de Picardie Jules Verne (UPJV), Amiens, France;3. Service d’Oncologie Médicale, CHU Amiens Sud, France;4. Université de Lille, Institut Pasteur de Lille, CNRS UMR8161 – M3T – Mechanisms of Tumourigenesis and Targeted Therapies, Lille, France;1. Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, Henan Province, China;2. The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, Henan Province, China;1. Key Laboratory of Precision Opto-mechatronics Technology, Ministry of Education, School of Instrumentation Science and Opto-electronics Engineering, Beihang University, Beijing 100191, China;2. School of Mathematics and System Science, Beihang University, Beijing 100191, China;1. Schizophrenia Research Center, Nathan Kline Institute, Orangeburg, NY, USA;2. Department of Psychiatry, Columbia University, New York, NY 10032, USA |
